New Delhi: India began the world’s largest immunisation exercise against the coronavirus on Saturday and 1.91 lakh people were inoculated across the country.
In phase one of the immunisation exercise, 3 crore people in the priority group of healthcare and frontline workers are to be vaccinated. On Saturday, 3,352 sessions were held, with the target of vaccinating at least 100 people each.
On the break-up of Covishield and Covaxin, the Ministry data showed that while the first vaccine, developed by Oxford-AstraZeneca and manufactured by Pune’s Serum Institute, had been supplied to all states and Union territories, the indigenously developed Covaxin was administered in “clinical trial mode” in 12 states, including the national capital. Each session site could administer only one of the two vaccines.
